Jane Fridlyand
- Molecular Biology top 0.5%
- Oncology top 0.5%
- Cancer Research top 0.5%
- Genetics top 1%
- Artificial Intelligence top 1%
- Co-authors
- Sandrine DudoitTerence P. SpeedBoris C. BastianDonna G. AlbertsonHetal PatelToshiro KageshitaKlaus J. BusamDan Pinkel
- Topics
- Genomic variations and chromosomal abnormalities (20 papers)Cancer Genomics and Diagnostics (16 papers)Gene expression and cancer classification (13 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Jane Fridlyand
66 papers receiving 10.3k citations
Hit Papers
Peers
Comparison fields: 5 of 193
- Molecular Biology 6.7k
- Oncology 3.5k
- Cancer Research 2.0k
- Genetics 1.4k
- Artificial Intelligence 1.1k
Countries citing papers authored by Jane Fridlyand
This map shows the geographic impact of Jane Fridlyand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Fridlyand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Fridlyand more than expected).
Fields of papers citing papers by Jane Fridlyand
This network shows the impact of papers produced by Jane Fridlyand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Fridlyand. The network helps show where Jane Fridlyand may publish in the future.
Co-authorship network of co-authors of Jane Fridlyand
This figure shows the co-authorship network connecting the top 25 collaborators of Jane Fridlyand. A scholar is included among the top collaborators of Jane Fridlyand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Fridlyand. Jane Fridlyand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 21 | |
| 4 | 149 | |
| 5 | 122 | |
| 6 | 243 | |
| 7 | 295 | |
| 8 | 67 | |
| 9 | Mutations in TP53 and associated genomic abnormalities are dependent on breast cancer estrogen receptor status and patient age | 1 |
| 10 | 1 | |
| 11 | 66 | |
| 12 | 73 | |
| 13 | 19 | |
| 14 | 65 | |
| 15 | 33 | |
| 16 | 22 | |
| 17 | 69 | |
| 18 | 7 | |
| 19 | 67 | |
| 20 | 487 |
About Jane Fridlyand
Jane Fridlyand is a scholar working on Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 68 papers that have together received 10.6k indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (20 papers), Cancer Genomics and Diagnostics (16 papers) and Gene expression and cancer classification (13 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (3.5k citations) and Molecular Biology (6.7k citations). Jane Fridlyand has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Sandrine Dudoit, Terence P. Speed, Boris C. Bastian, Donna G. Albertson, Hetal Patel, Toshiro Kageshita, Klaus J. Busam, Dan Pinkel, Hanni Willenbrock and Heinz Kutzner. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.